問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
夏和雄
下載
2019-08-01 - 2025-06-30
Condition/Disease
Test Drug
Participate Sites7Sites
Recruiting5Sites
Terminated2Sites
2025-02-28 - 2032-06-30
Participate Sites13Sites
Recruiting13Sites
2017-01-01 - 2028-12-31
Participate Sites6Sites
Recruiting6Sites
2023-01-31 - 2032-12-03
Participate Sites11Sites
Recruiting11Sites
2022-01-10 - 2028-12-01
2024-08-01 - 2028-11-05
Participate Sites4Sites
Recruiting4Sites
2024-09-01 - 2027-06-30
Participate Sites2Sites
Not yet recruiting1Sites
Recruiting1Sites
2018-05-30 - 2022-12-31
Hepatocellular Carcinoma (HCC)
ATG-008
Division of Hematology & Oncology
全部
